Cim, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Cim, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 May 17, 2024	SELL	$692.45 - $844.37 $751,308 - $916,141	-1,085 Closed	0 $0
Q2 2023 May 17, 2024	BUY	$700.03 - $830.35 $759,532 - $900,929	1,085 New	1,085 $779,000
Q1 2023 May 17, 2024	BUY	$680.49 - $826.97 $738,331 - $897,262	1,085 New	1,085 $891,000
Q4 2022 Feb 10, 2023	SELL	$705.89 - $766.39 $47,294 - $51,348	-67 Reduced 5.64%	1,121 $808,000
Q3 2022 Nov 02, 2022	SELL	$573.97 - $724.32 $27,550 - $34,767	-48 Reduced 3.88%	1,188 $903,000

Q2 2022 Jul 11, 2022	SELL	$548.35 - $738.84 $18,095 - $24,381	-33 Reduced 2.6%	1,236 $768,000
Q1 2022 Apr 12, 2022	BUY	$595.12 - $698.43 $755,207 - $886,307	1,269 New	1,269 $917,000
Q4 2020 Feb 08, 2021	SELL	$478.3 - $607.98 $526,130 - $668,778	-1,100 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$544.75 - $658.21 $3,813 - $4,607	7 Added 0.64%	1,100 $648,000
Q2 2020 Aug 07, 2020	SELL	$493.32 - $643.92 $526,372 - $687,062	-1,067 Closed	0 $0
Q1 2020 May 05, 2020	BUY	$336.18 - $494.43 $358,704 - $527,556	1,067 New	1,067 $521,000
Q4 2017 Jan 23, 2018	SELL	$358.63 - $469.95 $350,740 - $459,611	-978 Closed	0 $0
Q3 2017 Nov 03, 2017	BUY	$431.38 - $504.0 $5,176 - $6,048	12 Added 1.24%	978 $437,000
Q2 2017 Aug 09, 2017	BUY	N/A	966	966 $474,000

1,424

82.1M

835K

1.46M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $113B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Cim, LLC, based on Form 13F filings with the SEC.

Stay updated on Cim, LLC with notifications on news.